论文部分内容阅读
2015年开年伊始,羚锐集团再传利好消息,包括羚锐银杏保健茶、羚锐通便茶、羚锐辅助降压茶等在内的多个绿色产品获美国FDA认证,由此表明羚锐集团开拓国际市场取得实质性进展。2011年以来,羚锐集团借助自身在行业中的品牌影响力,坚持转变发展方式,坚持创新驱动发展,实施差异化、科技与管理创新、资源整合和资本运作战略,产业布局由单纯满足疾病治疗需要向满足治疗、预防、保健、养生、康
At the beginning of 2015, Lingrui Group passed the good news again. A number of green products including Lingrui Ginkgo Health Tea, Lingrui Recipe, Lingrui Aided Blood Pressure Tea, etc. have been accredited by the U.S. FDA, Sharp Group to explore the international market made substantial progress. Since 2011, Lingrui Group, with its own brand influence in the industry, has insisted on transforming its mode of development, insisting on innovation-driven development, implementing differentiation, technology and management innovation, resource integration and capital operation strategy. The industrial layout is composed of purely satisfying disease treatment Need to meet the treatment, prevention, health, health, health